Collection of hundreds of bacteria strains, creating a private strain bank. Microbiota samples taken from non-industrialised societies (human resident bacteria).

Characterisation of the strains’ mechanism of action, after selecting those with outstanding phenotypes

Patent protection.

Development of probiotic blends with relevant medical applications for every stage of life.

Complete in vitro and in vivo investigation process.

Clinical validation in humans. Gold standard randomised, double-blind, placebo- controlled clinical trials.

Generation of the final product concept (dose, delivery form, formulation and posology), following all quality and regulatory processes.

Development of a value proposition and positioning of the final product, taking into consideration specific market needs and competitors.

Proven safety and efficacy.